﻿<?xml version="1.0" encoding="utf-8"?><!--RSS Genrated: Tue, 14 Apr 2026 14:03:04 GMT--><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:ev="http://purl.org/rss/1.0/modules/event/"><channel><title>American Pharmacists Association</title><link>http://stage.pharmacist.com/Publications/Pharmacy-Today/October-2024/rss/2058</link><atom:link href="http://stage.pharmacist.com/Publications/Pharmacy-Today/October-2024/rss/2058" rel="self" type="application/rss+xml" /><description>RSS document</description><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[New and Approved]]></title><link>http://stage.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-29</link><description><![CDATA[  New drugs  

 PALOPEGTERIPARATIDE 
(Yorvipath—Ascendis Pharma) 

  Drug class:  Yorvipath is a parathyroid hormone analog. 

  Indication:  Yorvipath is indicated for the treatment of ...]]></description><pubDate>Sat, 07 Sep 2024 16:00:00 GMT</pubDate><guid>http://stage.pharmacist.com/Publications/Pharmacy-Today/Article/new-and-approved-29</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2648]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Gabapentinoid-loop diuretic study sheds light on broader cascade risks]]></title><link>http://stage.pharmacist.com/Publications/Pharmacy-Today/Article/gabapentinoid-loop-diuretic-study-sheds-light-on-broader-cascade-risks</link><description><![CDATA[  Elizabeth Briand  

 Prescribing cascades are under-recognized as a contributor to polypharmacy among older adults, according to a recent paper published in the  Journal of the American ...]]></description><pubDate>Sat, 07 Sep 2024 16:00:00 GMT</pubDate><guid>http://stage.pharmacist.com/Publications/Pharmacy-Today/Article/gabapentinoid-loop-diuretic-study-sheds-light-on-broader-cascade-risks</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2646]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[ACPE’s Jan Engle discusses new PharmD standards]]></title><link>http://stage.pharmacist.com/Publications/Pharmacy-Today/Article/acpes-jan-engle-discusses-new-pharmd-standards</link><description><![CDATA[  Loren Bonner  

   

  At a June 2024 meeting, the board of directors for the Accreditation Council for Pharmacy Education (ACPE) approved new accreditation standards for the PharmD degree. All ...]]></description><pubDate>Sat, 07 Sep 2024 16:00:00 GMT</pubDate><guid>http://stage.pharmacist.com/Publications/Pharmacy-Today/Article/acpes-jan-engle-discusses-new-pharmd-standards</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2647]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Smoking cessation with e-cigarettes raises concerns]]></title><link>http://stage.pharmacist.com/Publications/Pharmacy-Today/Article/smoking-cessation-with-e-cigarettes-raises-concerns</link><description><![CDATA[  Clarissa Chan, PharmD  

   

 A randomized placebo-controlled single-center Finnish study published in  JAMA Internal Medicine  on June 17, 2024, showed that varenicline and e-cigarettes had ...]]></description><pubDate>Sat, 07 Sep 2024 16:00:00 GMT</pubDate><guid>http://stage.pharmacist.com/Publications/Pharmacy-Today/Article/smoking-cessation-with-e-cigarettes-raises-concerns</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2649]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[A new maintenance treatment option for adults living with COPD]]></title><link>http://stage.pharmacist.com/Publications/Pharmacy-Today/Article/a-new-maintenance-treatment-option-for-adults-living-with-copd</link><description><![CDATA[  Lauren Howell, PharmD  

   

 In June 2024, for the first time in over a decade, FDA approved a new drug to treat adult patients with COPD. For the more than 16 million adults living with COPD ...]]></description><pubDate>Sat, 07 Sep 2024 16:00:00 GMT</pubDate><guid>http://stage.pharmacist.com/Publications/Pharmacy-Today/Article/a-new-maintenance-treatment-option-for-adults-living-with-copd</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2650]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Bitter melon supplements: A bitter pill?]]></title><link>http://stage.pharmacist.com/Publications/Pharmacy-Today/Article/bitter-melon-supplements-a-bitter-pill</link><description><![CDATA[  Mickie Cathers  

   

 Bitter melon dietary supplements are advertised as supporting healthy digestion and promoting increased metabolism and decreased body weight by balancing blood glucose ...]]></description><pubDate>Sat, 07 Sep 2024 16:00:00 GMT</pubDate><guid>http://stage.pharmacist.com/Publications/Pharmacy-Today/Article/bitter-melon-supplements-a-bitter-pill</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2653]]></dc:identifier></item><item><dc:creator><![CDATA[Roger Selvage]]></dc:creator><title><![CDATA[Don’t scratch that itch— soothe it!]]></title><link>http://stage.pharmacist.com/Publications/Pharmacy-Today/Article/dont-scratch-that-itch-soothe-it</link><description><![CDATA[  Mary Warner  

   

 Itchy skin, also known as pruritus, can be caused from many skin conditions, including eczema, dermatitis, and psoriasis; allergies; diseases such as shingles; or hormonal ...]]></description><pubDate>Sat, 07 Sep 2024 16:00:00 GMT</pubDate><guid>http://stage.pharmacist.com/Publications/Pharmacy-Today/Article/dont-scratch-that-itch-soothe-it</guid><dc:identifier><![CDATA[3fea3d08-a011-4455-a0c4-c8d47a98398c-2654]]></dc:identifier></item></channel></rss>